Ravi Salgia to Neoplastic Cells, Circulating
This is a "connection" page, showing publications Ravi Salgia has written about Neoplastic Cells, Circulating.
Connection Strength
1.100
-
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study. Invest New Drugs. 2017 06; 35(3):334-344.
Score: 0.578
-
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer. Anticancer Res. 2003 Jan-Feb; 23(1A):49-62.
Score: 0.216
-
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Oncotarget. 2016 Oct 11; 7(41):66880-66891.
Score: 0.140
-
Personalized treatment of lung cancer. Semin Oncol. 2011 Apr; 38(2):274-83.
Score: 0.096
-
Detection and analysis of lung cancer cells from body fluids using a rare event imaging system. Methods Mol Med. 2003; 75:423-30.
Score: 0.054
-
Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system. Clin Cancer Res. 2004 May 01; 10(9):3020-8.
Score: 0.015